As the year ends, Peru can look back on a catastrophic year both from the point of view of both the Covid pandemic and its economic consequences. An increase in cases over recent days may betoken a second wave.

On 16 December, ECLAC released its expected growth figures for Latin America and for individual countries. It forecast that GDP for the region as a whole would contract by 7.7% in 2020, and that for Peru it would do so by 12.9%. This is the worst figure for any country except Venezuela.

While the figure for 2020 may now be reasonably accurate, assessments for growth in 2021, however, are little more than guesswork. ECLAC believes that GDP for Latin America will recover by 3.7% and for Peru 9%. This does not appear to take into account a possible second wave of Covid-19.

For his part, Waldo Mendoza, Peru’s new finance minister, is more optimistic than ECLAC. He sees Peru’s economy contracting by less than 12% in 2020 with recovery next year of over 10%. MEF predictions usually err on the side of optimism.

Either way, production levels may not recover to pre-Covid levels until well into 2022.

The historical precedents for such a dramatic economic contraction are hard to establish. The most recent parallel was 1983 when a combination of the debt crisis and Niño-induced drought caused a 12% fall in GDP. Some historians point to the impact of the 1929 Wall Street crash on the Peruvian economy; others go even further back to the time of the War of the Pacific with Chile in the 1870s.

The causes of this year’s disastrous performance are not hard to identify. Peru’s lockdown was more prompt, severe and enduring than most others, leading to a collapse in internal demand because of the impact on people’s incomes, and a massive fall on the supply side of the economy, as well as the impact of Covid-19 on external demand for the country’s exports.

According to ECLAC, Peru’s (non-financial) public sector deficit stood at 7.7% of GDP in November 2020, due to a 17.2% drop in tax income and a 10.3% increase in spending. While current spending (on relief payments to households and firms) soared, capital spending on public investment projects was frozen for several months. Its full report on Peru’s economic performance can be found here.

Meanwhile last week, the number of registered Covid cases in Peru was approaching 1 million (991,518 to be precise on 17 December) and the death toll close to 37,000 (36,901 on the same date). Of those currently infected, over 4,000 remained in hospital with 1,000 on ventilators.

As we have pointed out previously, the number of cases and the death toll may have been significantly higher than those officially registered. Peru has one of the highest casualty rates in the world. Its lockdown failed in its attempts to arrest the spread of the virus while the pandemic exposed the chronic weakness of its public health system.

While the number of new cases has tended to decline over recent months, December has seen an increase in transmission, emergency bed occupancy, and deaths. There are widespread fears that the end-of-year celebrations may trigger a second wave. A second wave would clearly have negative economic implications.

Peru has preliminary agreements to receive vaccines from Pfizer and Covax Facility but has no firm contracts in place so far. According to Health Minister Pilar Mazzeti talks are under way with AstraZeneca and are scheduled with Johnson & Johnson and Novax. It appears that opposition in Congress had the effect of delaying the signing of a contract with Pfizer.